We are thrilled to announce that following thorough review, the independent Data Safety and Monitoring Board (DSMB) has recommended to continue the inclusion of patients undergoing minimally invasive spine fixation surgery (MISS) in the Phase 1b clinical trial. The decision was based on an extensive data review for the three patients of the first cohort that underwent single-level spine fixation surgery with four co-implanted BR-003 rings. After the positive advice, three patients in the second cohort will undergo two-level MISS with six co-implanted BR-003 rings. For open spine fixation procedures, the first cohort of three patients is still ongoing. SentryX would like to thank everyone involved in this important and exciting trial.